Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.


Displaying records 1 through 1 (1 total).

Food and Drug Administration, Office of Women's Health. 2011. Birth control guide. [Silver Spring, MD]: Food and Drug Administration, Office of Women's Health , 22 pp.

Annotation: This guide for consumers provides information about the different kinds of medicines and devices for birth control that have been approved by the Food and Drug Administration. The guide includes an introduction to birth control and covers the following topics: barrier methods, hormonal methods, emergency contraception, implanted devices, and permanent methods for men and for women. It is available in English and Spanish.

Contact: U.S. Food and Drug Administration, Office of Women's Health , WO Building 32, Room 2325, 10903 New Hampshire Avenue, Silver Spring, MD 20993, Telephone: (301) 796-9440 Fax: (301) 847-8604 Web Site: http://www.fda.gov/ForConsumers/ByAudience/ForWomen Available from the website.

Keywords: Consumer education materials, Contraception, Contraceptive agents, Contraceptive devices, Contraceptive implants, Contraceptive use, Emergency contraception, Pregnancy, Prevention, Spanish language materials

   

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.